2.05 USD
↘ 0.01 (0.24%)LIVE (AS OF 03:19 PM EDT)
TherapeuticsMD, Inc.
TXMDNASDAQ • USD
Market: OPEN
TXMD is currently priced at $2.05. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place TXMD at a fair price relative to peers.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.02
High?$2.08
Low?$2.02
Prev. Close?$2.05
Volume?12.4K
Avg. Volume?27.7K
VWAP?$2.04
Rel. Volume?0.45x
Bid / Ask
Bid?$2.04 × 100
Ask?$2.08 × 100
Spread?$0.04
Midpoint?$2.06
Valuation & Ratios
Market Cap?23.7M
Shares Out?11.6M
Float?8.3M
Float %?71.6%
P/E Ratio?N/A
P/B Ratio?0.87
EPS?-$0.02
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
Employees
1
Market Cap
23.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2002-01-28
Address
951 YAMATO ROAD, SUITE 220
BOCA RATON, FL 33431
Phone: 561-961-1900
BOCA RATON, FL 33431
Phone: 561-961-1900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?50
Short Sent.?90
Piotroski F-Score?2/9Weak
Altman Z-Score?-33.97Distress
Confidence?46%Low
Short InterestLow
Short % of Float?0.32%Low
Short Interest?26.4K
Days to Cover?1.3
Free Float8.3M
Avg Daily Volume20.9K
Settlement Date2026-09-15
Financial Health
Current Ratio?6.90Strong
Quick Ratio?6.90Strong
Cash Ratio?3.93Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score80/100
P/E?N/A▾
P/B?0.87CHEAP▾
Peers100
S&P97
P/S?7.26HIGH▾
Peers100
S&P16
P/FCF?7.6CHEAP▾
Peers100
S&P94
EV/EBITDA?-4.0CHEAP▾
S&P97
EV/Sales?4.45FAIR▾
Peers100
S&P41
Returns & Efficiency
ROE?-0.8%WEAK▾
S&P14
ROA?-0.6%WEAK▾
S&P6
Cash Flow & Enterprise
FCF?$3.1M
Enterprise Value?$14.5M
Fundamentals ratios updated end of day